View in EDS

Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom.

Saved in:

Bibliographic Details
Title:	Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom.
Authors:	Ye Y; Global Evidence and Outcomes, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA james.ye@takeda.com., Jiang B; Safety and Observational Statistics, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA., Manne S; Safety and Observational Statistics, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA., Moses PL; Clinical Science, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA., Almansa C; Clinical Science, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA., Bennett D; Global Evidence and Outcomes, Takeda Pharmaceutical Company Ltd, Cambridge, Massachusetts, USA.; Perelman School of Medicine, Adjunct, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Dolin P; Global Evidence and Outcomes, Takeda Development Centre Europe, London, UK., Ford AC; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.; Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Source:	Gut [Gut] 2021 Apr; Vol. 70 (4), pp. 644-653. Date of Electronic Publication: 2020 Jun 03.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1468-3288
DOI:	10.1136/gutjnl-2020-321277